Page 73 - 北京京煤集团总医院第十一届·2023学术年会论文集
P. 73

北京京煤集团总医院                                                          第十一届·2023 学术年会论文集

                    Polyp morphology               3         0.0    0.727  4.32(2.97-6.30)      0.001
                    Pedunculated
                    Polyp         Left semicolon   8         68.5   0.002  0.84(0.59-1.20)      0.346
                    location      Right semicolon   8        69.1   0.002  1.14(0.80-1.62)      0.482

                                  Adenomas         7         80.6   0.000  1.70(0.89-3.23)      0.105
                                  Non-adenomas     2         72.3   0.058  0.44(0.08-2.51)      0.356
                    Pathological
                                  Serrated polyps   3        0.0    0.723  0.71(0.20-2.44)      0.584
                    type
                                  proliferative    4         72.3   0.013  0.67(0.30-1.49)      0.327
                                  polyps
                                  malignancies     5         0.0    0.933  2.66(1.49-4.75)      0.001

                    Operational related factors
                                  EMR              6         52.2   0.063  2.34(1.44-3.82)      0.001
                    The      way  ESD              2         55.4   0.134  3.62(0.76-17.32)     0.107

                    polyps        HSP              4         89.6   0.000  1.95(0.75-5.04)      0.168
                    removed       HB               4         0.0    0.974  0.28(0.17-0.46)      0.001
                                  APC              2         99.6   0.000  3.60(0.00-52774.53)   0.794
                    Preventive wound management    2         0.0    0.837  0.95(0.58-1.55)      0.834

                                  inexperienced    3         87.9   0.000  1.55(0.42-5.69)      0.512
                    Endoscopists
                                  experienced      3         87.9   0.000  0.65(0.18-2.38)      0.514
                   APC:  argon  plasma  coagulation;  EMR:  endoscopic  mucosal  resection;  ESD:  endoscopic

                   submucosal dissection; HB: hot biopsy; HSP: hot snare polypectomy.
                   3.4.5. Multivariate logistic regression effect value meta-analysis
                   The pooled effects of several risk factors were examined, including male sex (4 studies  [3, 6, 18, 22]  ),
                   hypertension (7 studies  [13, 15, 16, 18, 19, 21, 22]  ), diabetes (3 studies  [16, 18, 21]  ), anticoagulation(2 studies

                   [19, 21]  ), aspirin (3 studies  [13, 18, 21]  ), polyp number ≥3 (2 studies  [3, 6]  ), polyp size (4 studies  [13, 15, 21,
                   23]  ), polyp size ≥10 mm (5 studies  [3, 6, 16, 18, 22]  ), polyp size> 10 mm (2 studies  [19, 20]  ), pedunculated
                   polyp (4 studies  [3, 19, 21, 22]  ), polyp located in right semicolon (5 studies  [15, 18, 19, 22, 23]  ), resection
                   mode EMR (4 studies  [3, 8, 16, 20]  ), and HSP (2 studies  [16, 20]  ). The results showed male sex (RR=1.41,

                   95% CI: 0.76-2.05, P < 0.05), hypertension (RR=1.47, 95% CI: 1.18-1.77, P < 0.05), diabetes
                   (RR=1.17, 95% CI: 0.29-2.06, P < 0.05), anticoagulation (RR=3.56, 95% CI: 0.66-6.46, P < 0.05),
                   aspirin (RR=1.46, 95% CI: 0.98-1.93, P < 0.05), polyp number ≥ 3 (RR=2.35, 95% CI: 0.88-3.82,
                   P < 0.05), polyp size (RR=1.17, 95% CI: 1.13-1.22, P < 0.05), polyp size ≥ 10 mm (RR=2.13, 95%

                   CI: 1.42-2.83, P < 0.05), polyp size > 10 mm (RR=3.65, 95% CI: 2.17-5.14, P < 0.05), pedunculated
                   polyp (RR=1.73, 95% CI: 0.33-3.12, P < 0.05), and polyp located in the right semicolon (RR=2.23,
                   95% CI: 1.38-3.08, P < 0.05) (Fig. S31-34,35a,36-41) were associated with an increased risk of

                   DPPB, while EMR (RR=1.69, 95% CI: -0.01-3.38, P > 0.05) and HSP resection modes (RR=1.63,
                   95% CI: -0.00-3.27, P=0.05) (Fig. S42-43) were not associated with the risk of DPPB (see Table 3).





                                                           - 69 -
   68   69   70   71   72   73   74   75   76   77   78